CLINICAL_TRIALS
ClinicalTrials.gov record update
An Open-label, Multi-center, Single-arm Phase 1/2 Study to Assess Tolerability, Safety and Efficacy of CRC01 in Adult Patients With Relapsed or Refractory Large B-cell Lymphoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04836507
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:11.647735+00:00
- Published At
- 2021-05-03T00:00:00+00:00
- Record Updated At
- 2021-05-03
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Relapsed Large B-cell Lymphoma", "Refractory Large B-cell Lymphoma", "Diffuse Large B-cell Lymphoma (DLBCL)", "Primary Mediastinal Large B-Cell Lymphoma (PMBCL)", "High-grade B-cell Lymphoma", "Transformed Follicular Lymphoma (TFL)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-05-03"- protocolSection.identificationModule.nctId
"NCT04836507"- protocolSection.identificationModule.officialTitle
"An Open-label, Multi-center, Single-arm Phase 1/2 Study to Assess Tolerability, Safety and Efficacy of CRC01 in Adult Patients With Relapsed or Refractory Large B-cell Lymphoma"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.